Baiyunshan: Subsidiary obtains drug registration certificate for freeze-dried human rabies vaccine

On December 25, Baiyunshan announced that Guangzhou Baiyunshan Biological Products Co., Ltd., a company within the scope of the consolidated financial statements, has received the "Drug Registration Certificate" issued by the National Medical Products Administration for the freeze-dried human rabies vaccine. As of now, Baiyunshan Biological has invested a total of approximately RMB 205.09 million in research and development expenses for the freeze-dried human rabies vaccine project.